All Stories

  1. Spotlight on crizotinib in the first-line treatment of ALK-positive advanced non-small-cell lung cancer: patients selection and perspectives

    Article • Lung Cancer Targets and Therapy, June 2016, Dove Medical Press

    Dr Adrien Costantini, vncent fallet

  2. Crizotinib : l’étude de phase III confirme notre pratique quotidienne…

    Article • Bulletin du Cancer, October 2013, Elsevier

    vncent fallet